Abstract Library

#2879 Lung Neuroendocrine Tumors: Experience of Medical Oncology Department of Hospital 1st November 1954 Oran

Introduction: Lung neuroendocrine tumors account for 25% of all neuroendocrine tumors. It is a heterogeneous group that meets morphological criteria; immunohistochemical and molecular; defining 4 groups: Typical and atypical carcinoid tumors, neuroendocrine carcinomas with large cell and small cells. Carcinoid syndrome is rare in these tumors and the treatment is based on surgery for localized forms and multimodal treatment for metastatic forms.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Kehili H, Bengueddach A, Kaid M, Allaoui M, Benabdellah H,

Keywords: lung neuroendocrine tumors, rare, prognosis,

#2703 Carcinoid Heart Disease: A Retrospective Study and a Multidisciplinary Proposal of a New Algorithm

Introduction: Development of carcinoid heart disease (CHD) is the major negative prognostic factor in patients with the carcinoid syndrome. The only effective treatment is valve replacement. However, the selection of candidates and determination of optimal timing remain unclear. Considerable variability in local treatment strategies exist

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Bousahba A,

Keywords: carcinoid heart disease, somatostatin analogue, neuroendocrine tumors,

#1921 Prognostic Factors That Mandate Long Term Follow Up Following Surgery for Appendiceal Neuroendocrine Tumours (aNETs)

Introduction: Appendiceal neuroendocrine tumours (aNETs) are usually diagnosed incidentally at appendicectomy and rarely recur. Current ENET guidelines inform their management and highlight areas of uncertainty.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Alabraba E, Banks M, Malik H, Fenwick S, Cuthbertson D,

Keywords: Appendix NET,

#1757 Therapeutic Strategies in Patients with Neuroendocrine Neoplasm: 30 Month Follow-Up pf Long Survivors from EPH Mostaganem and EHU Oran Medical Oncology

Introduction: Neuro docrine tumors are poorly known and infrequent tumors are, most of the time, diagnosed late, often occurring between the age of 40 and 60.They mainly appear in the gastro intestinal system, pancreas, bronchi, lungs, thymus and thyroid.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Bengueddach A, Kehili H, Negadi S, Yamouni M, Malika K,

Keywords: Neuroendocrine tumors, metastasis, somatostatin analogs,

#412 Single Institutional Series of Neuroendocrine Tumors Managed in the Australian Capital Territory

Introduction: Neuroendocrine tumors (NETs) have been regarded as indolent tumors with significantly variable clinical behavior. Limited information is available on long-term clinical outcome and clinically applicable prognostic factors.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Malik L, Chua Y, Yip D, Butt N,

Keywords: neuroendocrine tumor,